Physician

Gerard Dayle Henry, M.D.

According to 2025 Medicare claims, Gerard Henry, M.D. (NPI: 1508862905) practices urology in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Bossier, LA. This provider's primary affiliated billing organization is WK ADVANCED UROLOGY (NPI: 1922692813; TIN: 862072270) and primary practice location at 71111-2166. Henry is affiliated with the Health Plus Network (ACO ID: A4620), participating under the MSSP model.

Henry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 244,645 HCPCS/CPT codes, and received $524,751 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,583 prescription claims across 418 beneficiaries totaling $268,314 in drug costs, led by Gemtesa (Vibegron). DME data shows 13 claims. Open Payments data shows 113 records totaling $109,551. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $500,420 and ending at $524,751. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $240,993 and ending at $268,314. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $260 and ending at $886.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$417K$834K2015 Medicare payment: $500,420 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $520,544 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $312,648 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $605,796 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $834,436 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $570,517 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $617,020 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $594,414 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $516,946 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $524,751 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201565111,400$500,420
201664811,514$520,544
20174343,163$312,648
20185387,344$605,796
201967211,196$834,436
20206947,764$570,517
202157312,221$617,020
202254919,040$594,414
2023552105,271$516,946
2024516244,645$524,751

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$212K$424K2015 Drug cost: $240,993 (USD; Tot_Drug_Cst)2016 Drug cost: $290,970 (USD; Tot_Drug_Cst)2017 Drug cost: $105,450 (USD; Tot_Drug_Cst)2018 Drug cost: $150,780 (USD; Tot_Drug_Cst)2019 Drug cost: $169,819 (USD; Tot_Drug_Cst)2020 Drug cost: $276,024 (USD; Tot_Drug_Cst)2021 Drug cost: $256,144 (USD; Tot_Drug_Cst)2022 Drug cost: $375,556 (USD; Tot_Drug_Cst)2023 Drug cost: $423,745 (USD; Tot_Drug_Cst)2024 Drug cost: $268,314 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152821,252$240,993
20162911,366$290,970
20172731,006$105,450
20183401,550$150,780
20193841,486$169,819
20203801,532$276,024
20213441,341$256,144
20223531,198$375,556
20233621,371$423,745
20244181,583$268,314

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.5K$2.9K2015 Medicare payment: $804 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $670 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $222 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,357 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,872 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,764 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,922 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R38$804
2016N/R30$670
2017N/RN/RN/R
2018N/R11$222
2019N/R38$2,357
2020N/R48$2,872
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R13$2,764
2024N/R13$2,922

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more286419$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more313496$58
96372Injection of drug or substance under skin or into muscle87140$11
81003Automated urinalysis test181215$2
J3145Injection, testosterone undecanoate, 1 mg96242,250$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GemtesaVibegron924,664$73,650
MyrbetriqMirabegron853,540$51,625
Mirabegron ErMirabegron28980$10,444
Testosterone CypionateTestosterone Cypionate1317,153$7,250
Alfuzosin Hcl ErAlfuzosin Hcl20417,069$5,134

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R13$2,922

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$13,359COLOPLAST CORP
Research PaymentsReported research-related payment or transfer-of-value amount.27$96,192BLUEWIND MEDICAL
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gerard Dayle Henry, M.D.?

Tedicare shows public-source Medicare data for Gerard Dayle Henry, M.D. (NPI 1508862905), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerard Dayle Henry, M.D. have ACO affiliation data?

Gerard Dayle Henry, M.D. is shown with ACO affiliation data for Health Plus Network (MSSP, ACO ID A4620).

What billing organization is linked to Gerard Dayle Henry, M.D.?

Gerard Dayle Henry, M.D. is linked to WK ADVANCED UROLOGY (billing NPI 1922692813) in the available physician profile data.

Does Gerard Dayle Henry, M.D. have Open Payments data?

Gerard Dayle Henry, M.D. has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.